ACR 2015

November 11, 2015

Welcome and Introduction
Marc Hochberg, MD, MPH, MACP

Osteoarthritis: Drug Use and Risks
Philip Conaghan, MBBS, PhD, FRACP, FRCP

Evidence of Chondroitin Sulfate Disease-Modifying Effects in Osteoarthritis and Underlying Mechanisms
Johanne Martel-Pelletier, PhD

MOSAIC: 24-Month Study on Structural Changes in Knee Osteoarthritis Assessed by MRI With Chondroitin Sulfate
Jean-Pierre Pelletier, MD

Randomized Trial of Combined Glucosamine and Chondroitin on Inflammation and Oxidative Stress
Sandi L. Navarro, PhD

Question and Answer Session

Concluding Remarks
Marc Hochberg, MD, MPH, MACP

Any doubt?
Contact us and we will write
you as soon as posible.